Retention of cellular radiation sensitivity in cell and xenograft lines established from human melanoma surgical specimens
- PMID: 1551106
Retention of cellular radiation sensitivity in cell and xenograft lines established from human melanoma surgical specimens
Abstract
Six human melanoma xenograft lines have been established in athymic mice from metastatic lesions in six different patients. Permanent cell lines in monolayer culture have been established from four of the xenograft lines. The cellular radiation sensitivity of the donor patients' tumors, the xenograft lines, and the cell lines were measured in vitro. The Courtenay soft agar colony assay was used for the donor patients' tumors, and a conventional plastic surface colony assay was used for the cell lines, whereas both assays were used for the xenograft lines. The cell survival data were analyzed using the multitarget single-hit as well as the linear-quadratic model. The donor patients' tumors differed considerably in cellular radiation sensitivity (the D0 ranged from 0.85 +/- 0.08 to 1.17 +/- 0.09 Gy, the alpha from 0.25 +/- 0.06 to 0.87 +/- 0.14 Gy-1, and the surviving fraction at 2.0 Gy from 0.15 +/- 0.04 to 0.50 +/- 0.06). The xenograft lines showed similar survival curves in soft agar and on the plastic surface, and the survival curves of a xenograft line and the corresponding cell line were not significantly different. These survival curves were not significantly different from those of the donor patients' tumors, regardless of which survival curve parameter was considered, i.e., the cellular radiation sensitivity of the donor patients' tumors was retained in the cell and xenograft lines. Moreover, the cell and xenograft lines have growth properties in vitro and in vivo that render a wide variety of experiments possible. Consequently, they show great promise for future studies of human tumor radiation biology.
Similar articles
-
Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse.Cancer Res. 1989 Jun 15;49(12):3163-7. Cancer Res. 1989. PMID: 2655893
-
Influence of cellular, microenvironmental, and growth parameters on thermotolerance kinetics in vivo in human melanoma xenografts.Cancer Res. 1989 Sep 15;49(18):5027-32. Cancer Res. 1989. PMID: 2766273
-
Effects of stem cell factor on the growth and radiation survival of tumor cells.Cancer Res. 1995 Aug 1;55(15):3431-7. Cancer Res. 1995. PMID: 7542170
-
Radiation biology of malignant melanoma.Acta Radiol Oncol. 1986 Jan-Feb;25(1):1-10. doi: 10.3109/02841868609136368. Acta Radiol Oncol. 1986. PMID: 3010642 Review.
-
Xenograft model systems for human melanoma.Mol Med Today. 1996 Sep;2(9):394-403. doi: 10.1016/s1357-4310(96)10035-6. Mol Med Today. 1996. PMID: 8885259 Review.
Cited by
-
Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells.Br J Cancer. 1998 Dec;78(12):1547-58. doi: 10.1038/bjc.1998.722. Br J Cancer. 1998. PMID: 9862563 Free PMC article.
-
Surgery and radiotherapy in the treatment of cutaneous melanoma.Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi22-9. doi: 10.1093/annonc/mdp257. Ann Oncol. 2009. PMID: 19617294 Free PMC article. Review.
-
Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.Br J Cancer. 1999 Aug;80(11):1697-707. doi: 10.1038/sj.bjc.6690586. Br J Cancer. 1999. PMID: 10468285 Free PMC article.
-
Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.Br J Cancer. 1994 Jun;69(6):1000-5. doi: 10.1038/bjc.1994.196. Br J Cancer. 1994. PMID: 8198960 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical